Ketorolac Tromethamine Injection
Brand names: Ketorolac Tromethamine
Category: Analgesia/Addiction
Unavailable 13Available 12
FDA status: Current · Last FDA update: Sep 22, 2026 · First posted: Mar 23, 2018 (in shortage 8 years 6 months) · 7 manufacturers, 25 listed presentations
As of Sep 22, 2026, the FDA lists Ketorolac Tromethamine Injection as currently in shortage. Of 25 manufacturer presentations, 13 Unavailable, 12 Available.
Ask your pharmacist: which of the 7 manufacturers below can they order right now, and whether a different strength or form of Ketorolac Tromethamine Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10) NDC 0338-0069-10 |
Baxter Healthcare | Unavailable | Estimated recovery: October 2026 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) NDC 76045-107-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25) NDC 0641-6041-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01) NDC 0409-3793-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: December 2027 |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) NDC 25021-700-01 |
Sagent Pharmaceuticals | Unavailable | Estimated recovery: late September 2026, Product in transit |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25) NDC 62332-599-25 |
Alembic Pharmaceuticals | Available | - |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) NDC 63323-161-01 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
| Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01) NDC 25021-700-01 |
Gland Pharma Limited | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) NDC 76045-104-10 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) NDC 63323-162-02 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) NDC 63323-162-01 |
Fresenius Kabi USA, LLC | Unavailable | Next release October 2026. Check wholesalers for inventory. |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25) NDC 0641-6042-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25) NDC 0641-6043-25 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01) NDC 0409-3795-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25) NDC 62332-600-25 |
Alembic Pharmaceuticals | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25) NDC 0338-0072-25 |
Baxter Healthcare | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25) NDC 72266-119-25 |
Gland Pharma Limited | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) NDC 25021-701-02 |
Gland Pharma Limited | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) NDC 25021-701-01 |
Gland Pharma Limited | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25) NDC 72266-118-25 |
Gland Pharma Limited | Available | Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645. |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02) NDC 25021-701-02 |
Sagent Pharmaceuticals | Available | - |
| Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01) NDC 25021-701-01 |
Sagent Pharmaceuticals | Available | - |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) NDC 76045-105-20 |
Fresenius Kabi USA, LLC | Unavailable | Estimated recovery: TBD |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25) NDC 62332-601-25 |
Alembic Pharmaceuticals | Available | - |
| Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01) NDC 0409-3796-01 |
Hospira, Inc., a Pfizer Company | Unavailable | Next Delivery and Estimated Recovery; December 2027; Shortage per Manufacturer: Manufacturing Delay |
Related medications in shortage
Other Analgesia/Addiction medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Ketorolac Tromethamine Injection (FDA data as of Sep 22, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Ketorolac Tromethamine Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Check your inbox - click the confirmation link to activate
alerts for Ketorolac Tromethamine Injection.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/ketorolac-tromethamine-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).